HK1215167A1 - 可吸入藥用組合物和含有該藥用組合物的吸入器裝置 - Google Patents
可吸入藥用組合物和含有該藥用組合物的吸入器裝置Info
- Publication number
- HK1215167A1 HK1215167A1 HK16103141.4A HK16103141A HK1215167A1 HK 1215167 A1 HK1215167 A1 HK 1215167A1 HK 16103141 A HK16103141 A HK 16103141A HK 1215167 A1 HK1215167 A1 HK 1215167A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pharmaceutical compositions
- devices containing
- inhaler devices
- inhalable pharmaceutical
- inhalable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0091—Inhalators mechanically breath-triggered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13165799 | 2013-04-29 | ||
PCT/EP2014/058616 WO2014177520A1 (en) | 2013-04-29 | 2014-04-28 | Inhalable pharmaceutical compositions and the inhaler devices containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1215167A1 true HK1215167A1 (zh) | 2016-08-19 |
Family
ID=48190328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16103141.4A HK1215167A1 (zh) | 2013-04-29 | 2016-03-17 | 可吸入藥用組合物和含有該藥用組合物的吸入器裝置 |
Country Status (13)
Country | Link |
---|---|
US (1) | US20160074318A1 (zh) |
EP (1) | EP2991626A1 (zh) |
JP (1) | JP2016523823A (zh) |
KR (1) | KR20160030086A (zh) |
CN (1) | CN105338965A (zh) |
AU (1) | AU2014261539A1 (zh) |
BR (1) | BR112015027247A2 (zh) |
CA (1) | CA2910697A1 (zh) |
HK (1) | HK1215167A1 (zh) |
MX (1) | MX2015015150A (zh) |
RU (1) | RU2015150977A (zh) |
WO (1) | WO2014177520A1 (zh) |
ZA (1) | ZA201507706B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA41378A (fr) * | 2015-01-20 | 2017-11-28 | Teva Branded Pharmaceutical Prod R & D Inc | Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol |
US10799653B2 (en) * | 2017-01-09 | 2020-10-13 | United Therapeutics Corporation | Aerosol delivery device and method for manufacturing and operating the same |
GB201711233D0 (en) | 2017-07-12 | 2017-08-23 | Aston Particle Tech Ltd | Coating method |
CN109821118A (zh) * | 2017-11-23 | 2019-05-31 | 正大天晴药业集团股份有限公司 | 新型肺部药物输送系统 |
CN114728138A (zh) * | 2019-11-14 | 2022-07-08 | 艾克诺韦公司 | 吸入器分流 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9925934D0 (en) * | 1999-11-03 | 1999-12-29 | Glaxo Group Ltd | Novel apparatus and process |
GB0124523D0 (en) * | 2001-10-12 | 2001-12-05 | Glaxo Group Ltd | Pharmaceutical combination |
GB0324918D0 (en) * | 2003-10-24 | 2003-11-26 | Glaxo Group Ltd | Composition |
DE102007056263A1 (de) * | 2007-11-22 | 2009-05-28 | Siegfried Generics International Ag | Dosiervorrichtung zur Inhalierung einer pulverförmigen Substanz |
EP2100599A1 (en) * | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2221048A1 (en) * | 2009-02-18 | 2010-08-25 | Siegfried Generics International AG | Pharmaceutical composition for inhalation |
EP2571486A4 (en) * | 2010-05-20 | 2013-12-04 | Sun Pharma Advanced Res Co Ltd | DRY POWDER INHALATION COMPOSITION |
CN102266344A (zh) * | 2010-06-04 | 2011-12-07 | 北京阜康仁生物制药科技有限公司 | 一种用于治疗呼吸障碍的药物组合物 |
AR086042A1 (es) * | 2011-04-28 | 2013-11-13 | Galapagos Nv | Compuesto util para el tratamiento de enfermedades degenerativas e inflamatorias y composicion farmaceutica |
US20160158149A1 (en) * | 2013-04-29 | 2016-06-09 | Sanofi Sa | Inhalable Pharmaceutical Compositions and the Inhaler Devices Containing Them |
-
2014
- 2014-04-28 EP EP14720583.5A patent/EP2991626A1/en not_active Withdrawn
- 2014-04-28 AU AU2014261539A patent/AU2014261539A1/en not_active Abandoned
- 2014-04-28 BR BR112015027247A patent/BR112015027247A2/pt not_active Application Discontinuation
- 2014-04-28 US US14/787,727 patent/US20160074318A1/en not_active Abandoned
- 2014-04-28 CA CA2910697A patent/CA2910697A1/en not_active Abandoned
- 2014-04-28 CN CN201480034550.3A patent/CN105338965A/zh active Pending
- 2014-04-28 JP JP2016511033A patent/JP2016523823A/ja active Pending
- 2014-04-28 WO PCT/EP2014/058616 patent/WO2014177520A1/en active Application Filing
- 2014-04-28 MX MX2015015150A patent/MX2015015150A/es unknown
- 2014-04-28 KR KR1020157033946A patent/KR20160030086A/ko not_active Application Discontinuation
- 2014-04-28 RU RU2015150977A patent/RU2015150977A/ru not_active Application Discontinuation
-
2015
- 2015-10-14 ZA ZA2015/07706A patent/ZA201507706B/en unknown
-
2016
- 2016-03-17 HK HK16103141.4A patent/HK1215167A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CA2910697A1 (en) | 2014-11-06 |
BR112015027247A2 (pt) | 2017-07-25 |
WO2014177520A1 (en) | 2014-11-06 |
EP2991626A1 (en) | 2016-03-09 |
KR20160030086A (ko) | 2016-03-16 |
RU2015150977A (ru) | 2017-06-02 |
CN105338965A (zh) | 2016-02-17 |
MX2015015150A (es) | 2016-02-18 |
JP2016523823A (ja) | 2016-08-12 |
US20160074318A1 (en) | 2016-03-17 |
RU2015150977A3 (zh) | 2018-04-25 |
ZA201507706B (en) | 2017-01-25 |
AU2014261539A1 (en) | 2015-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL282042B1 (en) | Devices and methods for administering multiple units of drug | |
IL245211A0 (en) | an inhaler for the medicine | |
IL240290A0 (en) | History of pyridazinone-amide and pharmaceutical preparations containing them | |
RU2016118771A3 (en) | Co-crystals and pharmaceutical compositions comprising the same | |
HK1215388A1 (zh) | 可吸入藥用組合物和含有該藥用組合物的吸入器裝置 | |
PT3043773T (pt) | Composição farmacêutica de dose fixa estável composta por mometasona e olopatadina para administração nasal | |
HK1215191A1 (zh) | 低劑量醫藥組合物 | |
IL243322A0 (en) | Method and controlled dose inhaler | |
IL246045B (en) | Inhalable drugs | |
HK1215167A1 (zh) | 可吸入藥用組合物和含有該藥用組合物的吸入器裝置 | |
IL240666A0 (en) | Pharmaceutical preparations for oral administration and their uses | |
HK1219691A1 (zh) | 醫藥組成物及其用途 | |
HK1220651A1 (zh) | 用於吸入藥用物質的元件 | |
ZA201603463B (en) | An inhalable medicament | |
IL245760A0 (en) | Inhalation medicine | |
GB201307082D0 (en) | Pharmaceutical composition comprising 15-HETrE and methods of using the same |